Enhancement of Budesonide Dissolution and In-Vivo Pharmacokinetics via Nanoliposomal Drug Delivery System
The optimized BDNL3 formulations showed a sustained release profile and a 2.15-fold increase in bioavailability, which may provide a potential approach to overcome its poor oral absorption and improve therapeutic outcomes.